• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy.

出版信息

CADTH Technol Overv. 2010;1(1):e0105. Epub 2010 Mar 1.

PMID:22977393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3411136/
Abstract
摘要

相似文献

1
Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy.用于肺动脉高压的药物：联合治疗临床疗效的系统评价
CADTH Technol Overv. 2010;1(1):e0105. Epub 2010 Mar 1.
2
Up-front combination therapy in pulmonary arterial hypertension: from clinical trials to 'real world' observational studies.肺动脉高压的初始联合治疗：从临床试验到“真实世界”观察性研究
Int J Cardiol. 2014 May 15;173(3):349-50. doi: 10.1016/j.ijcard.2014.03.095. Epub 2014 Mar 21.
3
Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review.再生细胞疗法治疗动物模型中的肺动脉高压：系统评价。
Stem Cell Res Ther. 2019 Mar 6;10(1):75. doi: 10.1186/s13287-019-1172-6.
4
Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.静脉注射依前列醇转换为口服/吸入靶向肺动脉高压治疗儿童特发性和家族性肺动脉高压的疗效。
Am J Cardiol. 2010 May 15;105(10):1485-9. doi: 10.1016/j.amjcard.2009.12.075. Epub 2010 Apr 8.
5
Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension.肺动脉高压特异性治疗在日本肺动脉高压患者中的疗效和结局。
Circ J. 2017 Dec 25;82(1):275-282. doi: 10.1253/circj.CJ-17-0139. Epub 2017 Jul 26.
6
Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.动物模型中再生细胞疗法治疗肺动脉高压的疗效与安全性：一项临床前系统评价方案
Syst Rev. 2016 May 25;5:89. doi: 10.1186/s13643-016-0265-x.
7
Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta-analysis.肺动脉高压药物治疗的比较效果和安全性：系统评价和荟萃分析。
Chest. 2014 May;145(5):1055-1063. doi: 10.1378/chest.13-1864.
8
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.安立生坦和他达拉非联合治疗与肺动脉高压患者的死亡率：来自随机、对照 AMBITION 研究结果的二次分析。
Lancet Respir Med. 2016 Nov;4(11):894-901. doi: 10.1016/S2213-2600(16)30307-1. Epub 2016 Oct 11.
9
Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.肺动脉高压的药物治疗的实际考虑。
Pharmacotherapy. 2012 Sep;32(9):838-55. doi: 10.1002/j.1875-9114.2012.01114.x. Epub 2012 Jul 17.
10
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.口服西地那非与吸入伊洛前列素联合治疗重度肺动脉高压。
Ann Intern Med. 2002 Apr 2;136(7):515-22. doi: 10.7326/0003-4819-136-7-200204020-00008.

本文引用的文献

1
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.在肺动脉高压患者的长期静脉依前列醇治疗中添加西地那非：一项随机试验。
Ann Intern Med. 2008 Oct 21;149(8):521-30. doi: 10.7326/0003-4819-149-8-200810210-00004.
2
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.波生坦治疗轻度症状性肺动脉高压患者的研究（EARLY研究）：一项双盲、随机对照试验。
Lancet. 2008 Jun 21;371(9630):2093-100. doi: 10.1016/S0140-6736(08)60919-8.
3
Pulmonary arterial hypertension.肺动脉高压
J Am Coll Cardiol. 2008 Apr 22;51(16):1527-38. doi: 10.1016/j.jacc.2008.01.024.
4
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland.英国和爱尔兰临床实践中肺动脉高压管理的共识声明。
Thorax. 2008 Mar;63 Suppl 2:ii1-ii41. doi: 10.1136/thx.2007.090480.
5
Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.肺动脉高压的药物治疗：美国胸科医师学会循证临床实践指南（更新版）
Chest. 2007 Jun;131(6):1917-28. doi: 10.1378/chest.06-2674.
6
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.在肺动脉高压患者中，将吸入伊洛前列素添加到现有波生坦治疗方案中的随机研究。
Am J Respir Crit Care Med. 2006 Dec 1;174(11):1257-63. doi: 10.1164/rccm.200603-358OC. Epub 2006 Aug 31.
7
First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.使用波生坦和西地那非联合口服治疗肺动脉高压的首次经验。
Eur J Clin Invest. 2006 Sep;36 Suppl 3:32-8. doi: 10.1111/j.1365-2362.2006.01692.x.
8
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.肺动脉高压诊断和治疗指南。欧洲心脏病学会肺动脉高压诊断和治疗工作组。
Eur Heart J. 2004 Dec;25(24):2243-78. doi: 10.1016/j.ehj.2004.09.014.
9
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.波生坦与依前列醇联合用于肺动脉高压：BREATHE - 2研究
Eur Respir J. 2004 Sep;24(3):353-9. doi: 10.1183/09031936.04.00028404.